Eli Lilly Dan Skovronsky discusses weight loss drugs

Dan Skovronsky knows what a good drug of obesity does. As head of scientific officer in Eli LillyHe has already…

FDA approvals fall in 2024, Transcarent acquires Accolade

Signs are seen outside the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, on August 29, 2020. Andrew…

Eli Lilly's cholesterol pill impresses in trial

A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing the latest healthcare news directly to your…